Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Blood|July 31, 2020
Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab eraSabela Bobillo, Erel Joffe, Jessica A Lavery, et al.
Blood Advances|June 12, 2023
Retrospective characterization of nodal marginal zone lymphomaRobert Stuver, Esther Drill, David Qualls, et al.
The Journal of Infectious Diseases|June 30, 2021
Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 InfectionRebecca L Smith, Laura L Gibson, Pamela P Martinez, et al.
Blood Advances|April 20, 2023
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapyWilliam T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infectionRebecca L Smith, Laura L Gibson, Pamela P Martinez, et al.
Medrxiv : the Preprint Server for Health Sciences|July 20, 2021
Daily sampling of early SARS-CoV-2 infection reveals substantial heterogeneity in infectiousnessRuian Ke, Pamela P Martinez, Rebecca L Smith, et al.
American Journal of Human Genetics|October 28, 2008
CC2D2A is mutated in Joubert syndrome and interacts with the ciliopathy-associated basal body protein CEP290Nicholas T Gorden, Heleen H Arts, Melissa A Parisi, et al.
Nature Microbiology|April 28, 2022
Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousnessRuian Ke, Pamela P Martinez, Rebecca L Smith, et al.
Open Forum Infectious Diseases|July 6, 2022
Longitudinal Analysis of SARS-CoV-2 Vaccine Breakthrough Infections Reveals Limited Infectious Virus Shedding and Restricted Tissue DistributionRuian Ke, Pamela P Martinez, Rebecca L Smith, et al.
The Lancet. Haematology|November 26, 2021
Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trialJacob D Soumerai, Anthony R Mato, Ahmet Dogan, et al.
Pageof 19